Press release
Single-Cell Omics Market to Reach USD 12.2 Billion by 2034
Single-Cell Omics
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73503
This technological revolution is shaping the future of precision medicine, allowing researchers and clinicians to develop highly targeted diagnostics and therapies. According to Exactitude Consultancy, the Single-Cell Omics Market was valued at USD 4.5 billion in 2024 and is expected to reach USD 12.2 billion by 2034, growing at a strong CAGR of 11.2% between 2025 and 2034.
Market Overview
• Market Size (2024): USD 4.5 billion
• Forecast (2034): USD 12.2 billion
• CAGR (2025-2034): 11.2%
Key Growth Drivers
• Rising adoption of precision medicine and biomarker discovery.
• Increasing demand for oncology research and drug development tools.
• Advances in NGS, mass spectrometry, and single-cell sequencing technologies.
• Expanding applications in neurology, immunology, and developmental biology.
Key Challenges
• High cost of single-cell omics instruments and consumables.
• Complex data integration requiring advanced bioinformatics.
• Limited adoption in low- and middle-income countries due to infrastructure gaps.
Major Players
10x Genomics, Illumina, Thermo Fisher Scientific, Fluidigm (Standard BioTools), Bio-Rad Laboratories, Becton Dickinson, Agilent Technologies, Qiagen, Pacific Biosciences, and Bruker Corporation.
Segmentation Analysis
By Omics Type
• Genomics
• Transcriptomics
• Proteomics
• Epigenomics
• Metabolomics
• Multiomics Integration
By Technology
• Next-Generation Sequencing (NGS)
• Mass Cytometry
• Flow Cytometry
• PCR-Based Methods
• Microarrays
• Imaging-Based Omics
• Others
By Application
• Oncology
• Immunology
• Neurology
• Stem Cell & Developmental Biology
• Rare Diseases
• Infectious Diseases
• Others
By End User
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Contract Research Organizations (CROs)
Segmentation Summary:
Genomics and transcriptomics lead adoption, while multiomics integration is emerging as the fastest-growing segment. Oncology remains the largest application area, given the need to understand tumor heterogeneity, while neurology and rare diseases are gaining prominence. Academic and research institutions remain the primary users, though pharmaceutical companies are rapidly expanding their use for biomarker discovery and drug development.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73503/single-cell-omics-market
Regional Analysis
North America
• Largest market in 2024.
• Driven by robust funding, advanced genomics infrastructure, and widespread use of single-cell omics in cancer research.
• The U.S. dominates due to strong biotech and pharmaceutical activity.
Europe
• Strong growth in Germany, the UK, and France.
• EU-backed investments in life sciences research and precision medicine initiatives.
• Collaborations between universities and biopharma companies drive innovation.
Asia-Pacific
• Expected to post the fastest CAGR through 2034.
• Expanding genomic research and clinical applications in China, Japan, South Korea, and India.
• Large patient pool and growing healthcare investment create strong demand.
Middle East & Africa
• Growing adoption in GCC countries with new research centers.
• Infrastructure limitations hinder growth across many African nations.
Latin America
• Brazil and Mexico lead regional adoption.
• Expanding biotech sectors and participation in international research collaborations.
Regional Summary:
North America leads the market with advanced infrastructure and funding, while Asia-Pacific is the fastest-growing region due to large-scale genomics initiatives and healthcare investments. Europe remains steady with strong regulatory support, while Latin America and the Middle East are emerging with growing research and biotech activity.
Market Dynamics
Growth Drivers
1. Increasing demand for personalized medicine and targeted therapies.
2. Rising use of single-cell omics in oncology, immunology, and neurology research.
3. Advances in sequencing, mass cytometry, and imaging platforms.
4. Strong funding support from governments, academia, and private biotech firms.
Key Challenges
1. High infrastructure and equipment costs.
2. Complexity of bioinformatics data integration.
3. Limited awareness and expertise in emerging markets.
Latest Trends
• Expansion of single-cell multiomics integrating multiple data layers.
• Rising use of AI and machine learning for big data interpretation.
• Growth in liquid biopsy applications leveraging single-cell analysis.
• Emergence of spatial omics technologies for mapping cells in their native environment.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73503
Competitive Landscape
Major Players
• 10x Genomics
• Illumina
• Thermo Fisher Scientific
• Fluidigm (Standard BioTools)
• Bio-Rad Laboratories
• Becton Dickinson
• Agilent Technologies
• Qiagen
• Pacific Biosciences
• Bruker Corporation
Competitive Dynamics
The single-cell omics market is highly competitive, with 10x Genomics leading in single-cell sequencing platforms, Illumina dominating in genomics, and Thermo Fisher offering broad multiomics solutions. Companies like Fluidigm and BD focus on cytometry and microfluidics, while Pacific Biosciences and Bruker bring expertise in long-read sequencing and proteomics. Strategic collaborations between pharma, biotech, and research institutes are accelerating commercialization and clinical adoption.
Conclusion
The Single-Cell Omics Market is set for rapid growth, rising from USD 4.5 billion in 2024 to USD 12.2 billion by 2034, at a strong CAGR of 11.2%.
• Genomics and transcriptomics dominate current adoption, while multiomics integration is the next frontier.
• Oncology remains the largest application, but neurology, rare diseases, and immunology are expanding rapidly.
• North America leads adoption, while Asia-Pacific is the fastest-growing region.
• Advances in multiomics, spatial omics, and AI-powered bioinformatics are shaping the future landscape.
As single-cell omics continues to evolve, it will provide unprecedented insights into disease mechanisms, accelerate drug discovery, and unlock new possibilities in personalized medicine. Over the next decade, this market will redefine how diseases are diagnosed and treated, cementing its role as a cornerstone of biomedical innovation.
This report is also available in the following languages : Japanese (シングルセルオミクス市場), Korean (단일 세포 오믹스 시장), Chinese (单细胞组学市场), French (Marché des technologies omiques à cellule unique), German (Einzelzell-Omics-Markt), and Italian (Mercato delle omiche monocellulari), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73503/single-cell-omics-market#request-a-sample
Our More Reports:
mRNA Vaccine and Therapeutics Market
https://exactitudeconsultancy.com/reports/72890/mrna-vaccine-and-therapeutics-market
Antisense Oligonucleotides Market
https://exactitudeconsultancy.com/reports/72891/antisense-oligonucleotides-market
Cell Line Characterization and Cell Line Development Market
https://exactitudeconsultancy.com/reports/72892/cell-line-characterization-and-cell-line-development-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Single-Cell Omics Market to Reach USD 12.2 Billion by 2034 here
News-ID: 4184572 • Views: …
More Releases from Exactitude Consultancy
Single Cell Analysis Market to Reach USD 18.0 Billion by 2034
In modern life sciences and healthcare, the ability to understand biological processes at the single-cell level represents a major breakthrough. Traditional bulk analysis often masks cellular heterogeneity, while single cell analysis (SCA) technologies enable researchers to examine the unique genomic, transcriptomic, proteomic, and metabolic characteristics of individual cells. This is critical in fields like oncology, immunology, neurology, and regenerative medicine, where disease progression and treatment responses can vary significantly from…
Multiomics Market to Reach USD 17.8 Billion by 2034
In the era of precision medicine, understanding diseases at the molecular level is critical for developing effective diagnostics and therapies. Multiomics-the integration of multiple "omics" technologies such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics-has become a transformative approach in biomedical research. By combining insights across these domains, researchers can build a holistic view of biological systems, identify biomarkers, and tailor treatments to individual patients.
Download Full PDF Sample Copy of Market…
Sustainable Laboratory Plasticware Market to Reach USD 12.0 Billion by 2034
Laboratories worldwide rely heavily on plasticware-tubes, pipette tips, petri dishes, flasks, and storage containers-to support research and diagnostics. However, the growing use of single-use plastics in life sciences has raised significant environmental concerns, creating demand for sustainable alternatives. The sustainable laboratory plasticware market is emerging as a vital solution, focusing on recyclable, reusable, biodegradable, and energy-efficient products to reduce environmental impact while maintaining safety and performance.
Download Full PDF Sample Copy…
Medical Waste Management Market to Reach USD 25 Billion by 2034
As healthcare systems expand worldwide, the volume of medical waste is rising at an unprecedented rate. Hospitals, clinics, laboratories, and research centers generate a wide range of biomedical waste, including sharps, infectious materials, pharmaceuticals, and chemical by-products. Improper disposal of these wastes poses significant risks to human health and the environment, making medical waste management a critical component of global healthcare infrastructure.
Download Full PDF Sample Copy of Market Report @…
More Releases for Omics
Emerging Single-Cell Omics Market Trends: Product Innovation Marks A Milestone I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Single-Cell Omics Market Size Growth Forecast: What to Expect by 2025?
The size of the single-cell omics market has experienced rapid expansion in the last few years. From the year 2024 to 2025, an increase from $2.08 billion to $2.39 billion is projected, with an anticipated compound annual growth…
Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market: An Emer …
The Single-Cell Omics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Single-Cell Omics Market?
In recent times, there has been a significant expansion in the size of the single-cell omics market. It is predicted to increase from $2.08 billion…
Rising Prevalence Of Genetic Illnesses Drives Growth Of The Spatial Omics Market …
What combination of drivers is leading to accelerated growth in the spatial omics market?
The rising prevalence of genetic disorders is expected to drive the spatial omics market. Genetic diseases are caused by abnormalities in DNA and are increasing due to better awareness and diagnostic technologies. Spatial omics provides in-depth molecular and genetic maps, helping study these disorders. For instance, the World Health Organization (WHO) estimated that congenital diseases caused 240,000…
Prominent Single-Cell Omics Market Trend for 2025: Product Innovation Marks A Mi …
What industry-specific factors are fueling the growth of the single-cell omics market?
The escalation in the occurrence of cancer is forecasted to boost the expansion of the single-cell omics market in the future. Cancer includes various diseases that occur when irregular cells multiply uncontrollably, overstep their usual limits, and either metastasize to other organs or infiltrate nearby body parts in almost any organ or tissue. The detection of biomarkers for cancer…
Charnwood Discovery and Intelligent Omics Announce Strategic Collaboration
Charnwood Discovery a leading drug discovery research partner has announced a strategic collaboration with Intelligent OMICS Ltd (Intellomx) who specialise in applying artificial intelligence (AI) and Machine Learning (ML) to accelerate drug discovery.
The collaboration will enable Charnwood Discovery to enhance its already extensive drug discovery services through Intellomx's AI platform which enables the identification of previously unattainable targets.
Dr Francesca Sadler, Charnwood Discovery's Chief Commercial Officer commented:
"This exciting collaboration…
Al in Omics Studies Market Beyond Big Data: AI Algorithms Deciphering the Omics …
Global Al in Omics Studies Market Worth $5.44 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Al in Omics Studies Market- (By Offering (Software, Services), By Technology Platform (Sequencing, Epigenomics, Proteomics, Metabolomics, Others), By Application (Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Others), By End User (Academic and Research Institutes, Biopharmaceutical Company, Others))…
